May 06, 2016 7:16 PM ET


Company Overview of Syntaxin Ltd

Company Overview

Syntaxin Ltd., a biotechnology company, discovers and develops biopharmaceuticals that treat diseases through selective inhibition of cell secretory pathways. The company specializes in the design, recombinant expression, and purification of botulinum neurotoxins and targeted secretion inhibitors (TSIs). It develops TSIs for the treatment of a range of diseases, including endocrine, sensory and respiratory conditions, and oncology. The company was founded in 2005 and is based in Oxon, United Kingdom with an office facility in Abingdon, United Kingdom. As of July 15, 2013, Syntaxin Ltd. operates as a subsidiary of Ipsen S.A.

Units 4-10The Quadrant

Barton Lane


Oxon,  OX14 3YS

United Kingdom

Founded in 2005


44 1235 552 100


44 1235 552 200

Key Executives for Syntaxin Ltd

Chief Executive Officer, Director and Member of Executive Steering Committee
Age: 57
Chief Development Officer, Research Director and Member of Executive Steering Committee
Age: 62
Chief Medical Officer
Chief Business Officer and Member of Executive Steering Committee
Consultant and Member of Scientific Advisory Board
Age: 64
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
ProMetic BioSciences Ltd. Europe
UK Stem Cell Bank Europe
Bio Products Laboratory Holding Limited Europe
TopCat Research Limited Europe
Proximagen Group plc Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Syntaxin Ltd, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at